Evidence map›Paper›PMID 31801298›Full record

ReviewInternational journal of molecular sciences2019

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.

Julia Konovalova, Dmytro Gerasymchuk, Ilmari Parkkinen, Piotr Chmielarz, Andrii Domanskyi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it, 191 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Julia KonovalovaInstitute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-0534-8028
Dmytro GerasymchukInstitute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.
Ilmari ParkkinenInstitute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.
Piotr ChmielarzDepartment of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.
Andrii DomanskyiInstitute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-4755-5981
University of Helsinki · FIMaj Institute of Pharmacology · PL

Funding

Academy of Finland 293392, 319195
6 · The paper itself

Abstract

MicroRNAs are post-transcriptional regulators of gene expression, crucial for neuronal differentiation, survival, and activity. Age-related dysregulation of microRNA biogenesis increases neuronal vulnerability to cellular stress and may contribute to the development and progression of neurodegenerative diseases. All major neurodegenerative disorders are also associated with oxidative stress, which is widely recognized as a potential target for protective therapies. Albeit often considered separately, microRNA networks and oxidative stress are inextricably entwined in neurodegenerative processes. Oxidative stress affects expression levels of multiple microRNAs and, conversely, microRNAs regulate many genes involved in an oxidative stress response. Both oxidative stress and microRNA regulatory networks also influence other processes linked to neurodegeneration, such as mitochondrial dysfunction, deregulation of proteostasis, and increased neuroinflammation, which ultimately lead to neuronal death. Modulating the levels of a relatively small number of microRNAs may therefore alleviate pathological oxidative damage and have neuroprotective activity. Here, we review the role of individual microRNAs in oxidative stress and related pathways in four neurodegenerative conditions: Alzheimer's (AD), Parkinson's (PD), Huntington's (HD) disease, and amyotrophic lateral sclerosis (ALS). We also discuss the problems associated with the use of oversimplified cellular models and highlight perspectives of studying microRNA regulation and oxidative stress in human stem cell-derived neurons.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyotrophic Lateral SclerosisAnimalsGene Expression RegulationHumansHuntington DiseaseMicroRNAsMitochondriaNerve Tissue ProteinsNeuronsOxidation-ReductionOxidative StressParkinson DiseaseSignal TransductionAmyloid beta-PeptidesMicroRNAsNerve Tissue ProteinsALSAlzheimer’s diseaseHuntington’s diseasemicroRNAneurodegenerationoxidative stressParkinson’s diseaseROStranslation regulation

Identifiers

PMID31801298
PMCPMC6929013
OpenAlexW2991324851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.